Cargando…

Pregabalin for the treatment of generalized anxiety disorder: an update

A previous review summarized what was then known about the potential role of pregabalin in the treatment of patients with generalized anxiety disorder (GAD): this review provides an update on its pharmacological properties and presumed mechanism of action, the liability for abuse, and efficacy and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baldwin, David S, Ajel, Khalil, Masdrakis, Vasilios G, Nowak, Magda, Rafiq, Rizwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699256/ https://www.ncbi.nlm.nih.gov/pubmed/23836974 http://dx.doi.org/10.2147/NDT.S36453

Ejemplares similares

Role of pregabalin in the treatment of generalized anxiety disorder
por: Baldwin, David S, et al.
Publicado: (2007)

Anticonvulsant and antipsychotic medications in the pharmacotherapy of panic disorder: a structured review
por: Masdrakis, Vasilios G., et al.
Publicado: (2021)

Pregabalin for the treatment of generalized anxiety disorder
por: Khallouk, A., et al.
Publicado: (2022)

The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic
por: Strawn, Jeffrey R, et al.
Publicado: (2007)

Reduced Treatment-Emergent Sexual Dysfunction as a Potential Target in the Development of New Antidepressants
por: Baldwin, David S., et al.
Publicado: (2013)

A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal
por: Silva Miguel, Luís, et al.
Publicado: (2013)

Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective
por: Vera-Llonch, Montserrat, et al.
Publicado: (2009)

Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors
por: Álvarez, Enrique, et al.
Publicado: (2015)

Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale
por: Hong, James S. W., et al.
Publicado: (2021)

The effectiveness of Internet‐delivered treatment for generalized anxiety disorder: An updated systematic review and meta‐analysis
por: Eilert, Nora, et al.
Publicado: (2020)

Duloxetine in the treatment of generalized anxiety disorder
por: Wright, Alan, et al.
Publicado: (2009)

Treatment of postherpetic neuralgia: focus on pregabalin
por: Cappuzzo, Kimberly A
Publicado: (2009)

Yogic Breathing Instruction in Patients with Treatment-Resistant Generalized Anxiety Disorder: Pilot Study
por: Tiwari, Nupur, et al.
Publicado: (2019)

Threat reversal learning and avoidance habits in generalised anxiety disorder
por: Roberts, Clark, et al.
Publicado: (2022)

Pregabalin-associated movement disorders: A literature review
por: Rissardo, Jamir Pitton, et al.
Publicado: (2020)

On the Differential Diagnosis of Anxious from Nonanxious Major Depression by means of the Hamilton Scales
por: Konstantakopoulos, George, et al.
Publicado: (2013)

Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice
por: Ruiz, Miguel A, et al.
Publicado: (2015)

Treatment of generalized anxiety disorder
por: Pinder, Roger M
Publicado: (2007)

Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia
por: Bhusal, Santosh, et al.
Publicado: (2016)

Pregabalin for the management of fibromyalgia syndrome
por: Boomershine, Chad S
Publicado: (2010)

Pregabalin in Treatment-Refractory Fibromyalgia
por: Stacey, Brett R, et al.
Publicado: (2010)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan, Michelle Nigri, et al.
Publicado: (2015)

A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder
por: Ng, Qin Xiang, et al.
Publicado: (2021)

Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”
por: Bonnet, Udo, et al.
Publicado: (2021)

Neuro-stimulation Techniques for the Management of Anxiety Disorders: An Update
por: Kar, Sujita Kumar, et al.
Publicado: (2016)

Pregabalin in acute and chronic pain
por: Baidya, Dalim Kumar, et al.
Publicado: (2011)

Duloxetine in the treatment of generalized anxiety disorder
por: Norman, Trevor R, et al.
Publicado: (2008)

Treatment of Generalized Anxiety Disorder with Gabapentin
por: Markota, Matej, et al.
Publicado: (2017)

Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain
por: De Salas-Cansado, Marina, et al.
Publicado: (2012)

Morphine and pregabalin in the treatment of neuropathic pain
por: Wang, Yue, et al.
Publicado: (2017)

Pregabalin and priapism
por: Ramasamy, Ranjith
Publicado: (2014)

Pregabalin dependence
por: Singh, Akashdeep, et al.
Publicado: (2020)

Major depressive disorder with anxious features - the role of pregabalin
por: Carvalho, R. S., et al.
Publicado: (2023)

Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview
por: Vismara, Matteo, et al.
Publicado: (2020)

Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action
por: Millan, Mark J.
Publicado: (2022)

Management of treatment-resistant generalized anxiety disorder
por: Ansara, Elayne D.
Publicado: (2020)

Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review
por: Ishikawa, Hayahito, et al.
Publicado: (2021)

Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review
por: Freynhagen, Rainer, et al.
Publicado: (2016)

Effect of valproate and pregabalin on human anxiety-like behaviour in a randomised controlled trial
por: Bach, Dominik R., et al.
Publicado: (2018)

Effectiveness of Pregabalin for Treatment of Burning Mouth Syndrome
por: Amasyalı, Saliha Yeter, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ah4dd5fu1phnkq6u0j5ecevror